Open App
you are here:

Procter & Gamble Health Ltd.

BSE: 500126 | NSE: PGHL |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE199A01012 | SECTOR: Pharmaceuticals

BSE Live

Sep 26, 11:11
4031.90 -62.45 (-1.53%)
Volume
No Data Available
233
  • Prev. Close

    4094.35

  • Open Price

    4064.05

  • Bid Price (Qty.)

    4032.00 (5)

  • Offer Price (Qty.)

    4038.30 (1)

NSE Live

Sep 26, 11:12
4037.95 -56.35 (-1.38%)
Volume
AVERAGE VOLUME
5-Day
7,367
10-Day
17,404
30-Day
10,651
1,020
  • Prev. Close

    4094.30

  • Open Price

    4114.80

  • Bid Price (Qty.)

    4034.30 (5)

  • Offer Price (Qty.)

    4037.95 (2)

ANNOUNCEMENTS ON Procter&Gamble

  • Sep 22, 2022 16:48 Source: NSE

    Procter & Gamble Health Limited

    We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on September 21,2022, regarding the loss /misplacement of the share certificate(s).

  • Sep 22, 2022 16:41 Source: BSE

    Procter & Gamble Health - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on September 21,2022, regarding the loss /misplacement of the share certificate(s).

  • Sep 14, 2022 13:20 Source: BSE

    Procter & Gamble Health - Intimation Of Shifting Of The Registered Office Of The Company

    We wish to inform you that the Board of Directors of the Company at their meeting held on August 29, 2022 have approved shifting the registered office address of the Company from 'Godrej One, 8th Floor, Pirojshanagar, Eastern Express Highway, Vikhroli East Mumbai 400 079' to 'P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai - 400099' w.e.f. January 1, 2023.This is for your information and records.

  • Sep 12, 2022 18:31 Source: BSE

    Procter & Gamble Health - Related Party Transactions For Six Months And Second Half Year Ended June 30, 2022

    We are enclosing herewith the Related Party Transactions for six months and second half year ended June 30, 2022.Kindly take the same on record and oblige.

  • Aug 29, 2022 19:42 Source: BSE

    Procter & Gamble Health - Update On Financial Results

    We would like to inform that, we had inadvertently missed attaching cash flow statement while uploading our financial results for the year ended June 30, 2022, approved by the Board at its meeting held today.Request you to kindly note that, initial submission made with the exchange, was made within the prescribed timeline and this is only a revision to the same, due to an inadvertent error as described above.We are hereby re-uploading a full set of results, for your perusal.

  • Aug 29, 2022 15:17 Source: BSE

    Procter & Gamble Health - Corporate Action-Board approves Dividend

    We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs.11.50 per equity share, for the financial year ended June 30, 2022. The dividend shall be paid between November 28, 2022 to December 18, 2022, on approval of the Members at the 55th Annual General Meeting.

  • Aug 29, 2022 15:16 Source: BSE

    Procter & Gamble Health - We Are Pleased To Inform You That At The Meeting Of The Board Of Directors Of The Company Held Today (Commenced At 12.45 Pm And Ended At 2:55 Pm), The Audited Financial Results For Financial Year Ended June 30, 2022 Were App

    We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 12.45 pm and ended at 2:55 pm), the Audited Financial Results for Financial Year ended June 30, 2022 were approved. We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended June 30, 2022, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. Press Release; and d. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results

  • Aug 29, 2022 15:16 Source: BSE

    Procter & Gamble Health - We Are Pleased To Inform You That At The Meeting Of The Board Of Directors Of The Company Held Today (Commenced At 12.45 Pm And Ended At 2:55 Pm), The Audited Financial Results For Financial Year Ended June 30, 2022 Were App

    We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 12.45 pm and ended at 2:55 pm), the Audited Financial Results for Financial Year ended June 30, 2022 were approved. We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended June 30, 2022, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. Press Release; and d. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results

  • Aug 29, 2022 15:13 Source: BSE

    Procter & Gamble Health - Board Meeting Outcome for Outcome Of Board Meeting- Audited Financial Results And Dividend

    We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 12.45 pm and ended at 2:55 pm), the Audited Financial Results for Financial Year ended June 30, 2022 were approved. We are enclosing herewith the following: Audited Financial Results for the Financial Year ended June 30, 2022, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; Press Release; and declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs.11.50 per equity share, for the financial year ended June 30, 2022.

BOARD MEETING

Meeting Date : Aug 29, 2022
Remark : Audited Results & Final Dividend